Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

813.00
10:24am EST
Change (% chg)

5.90₪ (+0.73%)
Prev Close
811.40₪
Open
812.00₪
Day's High
827.00₪
Day's Low
812.00₪
Volume
49,844
Avg. Vol
138,423
52-wk High
1,845.00₪
52-wk Low
668.80₪

PLX.TA

Chart for PLX.TA

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant... (more)

Overall

Beta: 1.37
Market Cap(Mil.): ₪775.30
Shares Outstanding(Mil.): 93.67
Dividend: --
Yield (%): --

Financials

  PLX.TA Industry Sector
P/E (TTM): -- 201.01 40.63
EPS (TTM): -1.38 -- --
ROI: -41.40 -0.92 18.22
ROE: -- -2.73 19.13
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks